Insider Trades102 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 26, 2026 | Sell | EXEL | Dana Aftab | EVP, Research and Development | 43,451 | $50.35 | $14.1B | -2.87% | +65.66% | $2.2M | -6.81% | — | Buy Now |
| May 20, 2026 | Sell | EXEL | Patrick J. Haley | EVP, Commercial | 32,110 | $49.81 | $14.1B | -2.87% | +65.66% | $1.6M | -8.24% | — | Buy Now |
| May 15, 2026 | Sell | EXEL | Brenda Hefti | SVP and General Counsel | 13,036 | $50.65 | $14.1B | -2.87% | +65.66% | $660.2K | -5.59% | 10b5-1 | Buy Now |
| May 15, 2026 | Sell | EXEL | Dana Aftab | EVP, Research and Development | 30,578 | $51.10 | $14.1B | -2.87% | +65.66% | $1.6M | -4.57% | — | Buy Now |
| May 15, 2026 | Sell | EXEL | Patrick J. Haley | EVP, Commercial | 33,265 | $51.10 | $14.1B | -2.87% | +65.66% | $1.7M | -7.86% | — | Buy Now |
| May 15, 2026 | Sell | EXEL | Christopher J. Senner | EVP and CFO | 75,793 | $50.59 | $14.1B | -2.87% | +65.66% | $3.8M | -3.76% | — | Buy Now |
| May 15, 2026 | Sell | EXEL | Michael Morrissey | President and CEO | 376,591 | $17.44 | $14.1B | -2.87% | +65.66% | $6.6M | -2.58% | — | Buy Now |
| May 6, 2026 | Sell | EXEL | Michael Morrissey | President and CEO | 109,676 | $48.70 | $14.1B | -2.87% | +65.66% | $5.3M | -5.51% | — | Buy Now |
| Feb 24, 2026 | Sell | EXEL | Dana Aftab | EVP, Research and Development | 47,918 | $44.50 | $14.1B | -2.87% | +65.66% | $2.1M | -7.22% | — | Buy Now |
| Feb 24, 2026 | Sell | EXEL | Michael Morrissey | President and CEO | 100,278 | $45.14 | $14.1B | -2.87% | +65.66% | $4.5M | -4.80% | — | Buy Now |
| Feb 19, 2026 | Sell | EXEL | Dana Aftab | EVP, Research and Development | 29,873 | $44.35 | $14.1B | -2.87% | +65.66% | $1.3M | -4.31% | — | Buy Now |
| Feb 15, 2026 | Sell | EXEL | Brenda Hefti | SVP and General Counsel | 24,099 | $43.99 | $14.1B | -2.87% | +65.66% | $1.1M | -10.22% | 10b5-1 | Buy Now |
| Feb 15, 2026 | Sell | EXEL | Dana Aftab | EVP, Research and Development | 39,205 | $43.92 | $14.1B | -2.87% | +65.66% | $1.7M | -2.72% | — | Buy Now |
| Feb 15, 2026 | Sell | EXEL | Patrick J. Haley | EVP, Commercial | 99,297 | $43.64 | $14.1B | -2.87% | +65.66% | $4.3M | -7.21% | — | Buy Now |
| Feb 13, 2026 | Sell | EXEL | Christopher J. Senner | EVP and CFO | 100,765 | $43.53 | $14.1B | -2.87% | +65.66% | $4.4M | -3.22% | — | Buy Now |
| Feb 13, 2026 | Buy | EXEL | Michael Morrissey | President and CEO | 1,736,356 | $18.47 | $14.1B | -2.87% | +65.66% | $32.1M | +0.04% | — | Buy Now |
| Jan 15, 2026 | Sell | EXEL | Dana Aftab | EVP, Research and Development | 27,254 | $45.23 | $14.1B | -2.87% | +65.66% | $1.2M | -3.58% | — | Buy Now |
| Jan 15, 2026 | Sell | EXEL | Patrick J. Haley | EVP, Commercial | 32,332 | $45.23 | $14.1B | -2.87% | +65.66% | $1.5M | -6.30% | — | Buy Now |
| Jan 15, 2026 | Sell | EXEL | Christopher J. Senner | EVP and CFO | 40,459 | $45.23 | $14.1B | -2.87% | +65.66% | $1.8M | -3.62% | — | Buy Now |
| Jan 15, 2026 | Sell | EXEL | Michael Morrissey | President and CEO | 139,524 | $45.23 | $14.1B | -2.87% | +65.66% | $6.3M | -7.10% | — | Buy Now |
| Nov 21, 2025 | Sell | EXEL | Dana Aftab | EVP, Research and Development | 24,000 | $42.51 | $14.1B | -2.87% | +65.66% | $1.0M | -3.61% | — | Buy Now |
| Nov 20, 2025 | Sell | EXEL | Patrick J. Haley | EVP, Commercial | 72,230 | $42.18 | $14.1B | -2.87% | +65.66% | $3.0M | -8.51% | — | Buy Now |
| Nov 11, 2025 | Sell | EXEL | Dana Aftab | EVP, Research and Development | 48,383 | $42.50 | $14.1B | -2.87% | +65.66% | $2.1M | -6.78% | — | Buy Now |
| Nov 11, 2025 | Sell | EXEL | Michael Morrissey | President and CEO | 443,096 | $42.98 | $14.1B | -2.87% | +65.66% | $19.0M | -3.50% | — | Buy Now |
| May 20, 2025 | Sell | EXEL | Patrick J. Haley | EVP, Commercial | 34,387 | $44.06 | $14.1B | -2.87% | +65.66% | $1.5M | -7.70% | — | Buy Now |
| May 15, 2025 | Sell | EXEL | Dana Aftab | CSO/EVP Disc & Trans Research | 30,693 | $44.65 | $14.1B | -2.87% | +65.66% | $1.4M | -4.43% | — | Buy Now |
| May 15, 2025 | Sell | EXEL | Jeffrey Hessekiel | EVP & General Counsel | 59,035 | $45.30 | $14.1B | -2.87% | +65.66% | $2.7M | -4.01% | — | Buy Now |
| May 15, 2025 | Sell | EXEL | Amy C. Peterson | EVP Prod Dev & Med Aff & CMO | 121,079 | $37.58 | $14.1B | -2.87% | +65.66% | $4.5M | -2.47% | — | Buy Now |
| May 15, 2025 | Sell | EXEL | Christopher J. Senner | EVP and CFO | 241,422 | $34.50 | $14.1B | -2.87% | +65.66% | $8.3M | -1.36% | — | Buy Now |
| May 14, 2025 | Sell | EXEL | Patrick J. Haley | EVP, Commercial | 287,471 | $35.57 | $14.1B | -2.87% | +65.66% | $10.2M | -2.23% | 10b5-1 | Buy Now |
| May 14, 2025 | Sell | EXEL | Michael Morrissey | President and CEO | 809,370 | $25.11 | $14.1B | -2.87% | +65.66% | $20.3M | -0.20% | — | Buy Now |
| May 1, 2025 | Sell | EXEL | Dana Aftab | CSO/EVP Disc & Trans Research | 1,508 | $39.00 | $14.1B | -2.87% | +65.66% | $58.8K | -0.22% | — | Buy Now |
| Mar 3, 2025 | Sell | EXEL | Patrick J. Haley | EVP, Commercial | 10,000 | $38.80 | $14.1B | -2.87% | +65.66% | $388.0K | -2.85% | 10b5-1 | Buy Now |
| Feb 24, 2025 | Sell | EXEL | Dana Aftab | CSO/EVP Disc & Trans Research | 26,987 | $36.75 | $14.1B | -2.87% | +65.66% | $991.8K | -5.01% | — | Buy Now |
| Feb 24, 2025 | Sell | EXEL | Christopher J. Senner | EVP and CFO | 58,628 | $27.47 | $14.1B | -2.87% | +65.66% | $1.6M | +0.00% | — | Buy Now |
| Feb 24, 2025 | Sell | EXEL | Patrick J. Haley | EVP, Commercial | 52,636 | $36.98 | $14.1B | -2.87% | +65.66% | $1.9M | -14.79% | — | Buy Now |
| Feb 24, 2025 | Sell | EXEL | Michael Morrissey | President and CEO | 355,970 | $37.13 | $14.1B | -2.87% | +65.66% | $13.2M | +0.00% | — | Buy Now |
| Feb 15, 2025 | Sell | EXEL | Jeffrey Hessekiel | EVP & General Counsel | 18,134 | $35.00 | $14.1B | -2.87% | +65.66% | $634.7K | -3.22% | — | Buy Now |
| Feb 15, 2025 | Sell | EXEL | Patrick J. Haley | EVP, Commercial | 18,906 | $35.00 | $14.1B | -2.87% | +65.66% | $661.7K | -5.04% | — | Buy Now |
| Feb 15, 2025 | Sell | EXEL | Christopher J. Senner | EVP and CFO | 21,591 | $35.00 | $14.1B | -2.87% | +65.66% | $755.7K | -2.69% | — | Buy Now |
| Feb 15, 2025 | Sell | EXEL | Dana Aftab | CSO/EVP Disc & Trans Research | 28,748 | $35.00 | $14.1B | -2.87% | +65.66% | $1.0M | -2.57% | — | Buy Now |
| Feb 15, 2025 | Sell | EXEL | Michael Morrissey | President and CEO | 63,570 | $35.00 | $14.1B | -2.87% | +65.66% | $2.2M | -5.83% | — | Buy Now |
| Jan 16, 2025 | Sell | EXEL | Dana Aftab | CSO/EVP Disc & Trans Research | 22,570 | $37.27 | $14.1B | -2.87% | +65.66% | $841.2K | -3.82% | — | Buy Now |
| Jan 16, 2025 | Sell | EXEL | Jeffrey Hessekiel | EVP & General Counsel | 26,289 | $37.27 | $14.1B | -2.87% | +65.66% | $979.8K | -4.46% | — | Buy Now |
| Jan 16, 2025 | Sell | EXEL | Patrick J. Haley | EVP, Commercial | 27,563 | $37.27 | $14.1B | -2.87% | +65.66% | $1.0M | -6.85% | — | Buy Now |
| Jan 16, 2025 | Sell | EXEL | Christopher J. Senner | EVP and CFO | 35,949 | $37.27 | $14.1B | -2.87% | +65.66% | $1.3M | -4.29% | — | Buy Now |
| Jan 16, 2025 | Sell | EXEL | Michael Morrissey | President and CEO | 120,244 | $37.27 | $14.1B | -2.87% | +65.66% | $4.5M | -9.94% | — | Buy Now |
| Dec 20, 2024 | Sell | EXEL | Michael Morrissey | President and CEO | 359,576 | $33.29 | $14.1B | -2.87% | +65.66% | $12.0M | +0.00% | — | Buy Now |
| Nov 27, 2024 | Sell | EXEL | Jeffrey Hessekiel | EVP & General Counsel | 303,222 | $26.99 | $14.1B | -2.87% | +65.66% | $8.2M | -2.03% | — | Buy Now |
| Nov 22, 2024 | Sell | EXEL | Patrick J. Haley | EVP, Commercial | 10,000 | $35.27 | $14.1B | -2.87% | +65.66% | $352.7K | -3.46% | 10b5-1 | Buy Now |
| Nov 15, 2024 | Sell | EXEL | Dana Aftab | CSO/EVP Disc & Trans Research | 12,838 | $35.05 | $14.1B | -2.87% | +65.66% | $450.0K | -2.57% | — | Buy Now |
| Nov 15, 2024 | Sell | EXEL | Jeffrey Hessekiel | EVP & General Counsel | 14,672 | $35.05 | $14.1B | -2.87% | +65.66% | $514.3K | -2.77% | — | Buy Now |
| Nov 15, 2024 | Sell | EXEL | Christopher J. Senner | EVP and CFO | 17,506 | $35.05 | $14.1B | -2.87% | +65.66% | $613.6K | -2.43% | — | Buy Now |
| Nov 15, 2024 | Sell | EXEL | Amy C. Peterson | EVP Prod Dev & Med Aff & CMO | 27,224 | $35.05 | $14.1B | -2.87% | +65.66% | $954.2K | -8.45% | — | Buy Now |
| Nov 15, 2024 | Sell | EXEL | Michael Morrissey | President and CEO | 47,642 | $35.05 | $14.1B | -2.87% | +65.66% | $1.7M | -4.94% | — | Buy Now |
| Nov 15, 2024 | Sell | EXEL | Patrick J. Haley | EVP, Commercial | 56,260 | $34.54 | $14.1B | -2.87% | +65.66% | $1.9M | -5.72% | 10b5-1 | Buy Now |
| Nov 5, 2024 | Sell | EXEL | Dana Aftab | CSO/EVP Disc & Trans Research | 193,972 | $26.90 | $14.1B | -2.87% | +65.66% | $5.2M | +0.00% | 10b5-1 | Buy Now |
| Nov 1, 2024 | Sell | EXEL | Jeffrey Hessekiel | EVP & General Counsel | 50,000 | $34.13 | $14.1B | -2.87% | +65.66% | $1.7M | -8.62% | 10b5-1 | Buy Now |
| Oct 31, 2024 | Sell | EXEL | Michael Morrissey | President and CEO | 46,000 | $33.20 | $14.1B | -2.87% | +65.66% | $1.5M | -3.17% | — | Buy Now |
| Oct 30, 2024 | Sell | EXEL | Dana Aftab | CSO/EVP Disc & Trans Research | 1,162 | $31.40 | $14.1B | -2.87% | +65.66% | $36.5K | -0.23% | 10b5-1 | Buy Now |
| Oct 28, 2024 | Sell | EXEL | Jeffrey Hessekiel | EVP & General Counsel | 25,000 | $28.39 | $14.1B | -2.87% | +65.66% | $709.8K | -4.13% | 10b5-1 | Buy Now |
| Oct 2, 2024 | Buy | EXEL | Patrick J. Haley | EVP, Commercial | 196,111 | $25.43 | $14.1B | -2.87% | +65.66% | $5.0M | +0.50% | — | Buy Now |
| Oct 1, 2024 | Buy | EXEL | Michael Morrissey | President and CEO | 976,298 | $24.49 | $14.1B | -2.87% | +65.66% | $23.9M | +0.34% | — | Buy Now |
| Sep 23, 2024 | Sell | EXEL | Jeffrey Hessekiel | EVP & General Counsel | 25,000 | $26.38 | $14.1B | -2.87% | +65.66% | $659.5K | -3.97% | 10b5-1 | Buy Now |
| Aug 26, 2024 | Sell | EXEL | Jeffrey Hessekiel | EVP, General Counsel & Sec | 40,000 | $25.10 | $14.1B | -2.87% | +65.66% | $1.0M | +0.00% | 10b5-1 | Buy Now |
| Aug 12, 2024 | Sell | EXEL | Dana Aftab | CSO/EVP Disc & Trans Research | 20,883 | $27.06 | $14.1B | -2.87% | +65.66% | $565.1K | -4.01% | — | Buy Now |
| Aug 9, 2024 | Sell | EXEL | Christopher J. Senner | EVP and CFO | 250,000 | $25.80 | $14.1B | -2.87% | +65.66% | $6.5M | +0.00% | — | Buy Now |
| Aug 7, 2024 | Sell | EXEL | Patrick J. Haley | EVP, Commercial | 14,000 | $25.50 | $14.1B | -2.87% | +65.66% | $357.0K | -3.94% | 10b5-1 | Buy Now |
| Aug 7, 2024 | Sell | EXEL | Jeffrey Hessekiel | EVP, General Counsel & Sec | 160,000 | $25.19 | $14.1B | -2.87% | +65.66% | $4.0M | +0.00% | 10b5-1 | Buy Now |
| Aug 7, 2024 | Sell | EXEL | Dana Aftab | CSO/EVP Disc & Trans Research | 190,000 | $24.70 | $14.1B | -2.87% | +65.66% | $4.7M | +0.00% | 10b5-1 | Buy Now |
| May 15, 2024 | Sell | EXEL | Dana Aftab | CSO/EVP Disc & Trans Research | 22,605 | $20.99 | $14.1B | -2.87% | +65.66% | $474.5K | -1.40% | — | Buy Now |
| May 15, 2024 | Sell | EXEL | Jeffrey Hessekiel | EVP, General Counsel & Sec | 25,941 | $20.99 | $14.1B | -2.87% | +65.66% | $544.5K | -1.33% | — | Buy Now |
| May 15, 2024 | Sell | EXEL | Christopher J. Senner | EVP and CFO | 30,310 | $20.99 | $14.1B | -2.87% | +65.66% | $636.2K | -1.36% | — | Buy Now |
| May 15, 2024 | Sell | EXEL | Patrick J. Haley | EVP, Commercial | 31,044 | $20.99 | $14.1B | -2.87% | +65.66% | $651.6K | -2.06% | — | Buy Now |
| May 15, 2024 | Sell | EXEL | Michael Morrissey | President and CEO | 73,943 | $20.99 | $14.1B | -2.87% | +65.66% | $1.6M | -3.62% | — | Buy Now |
| Feb 23, 2024 | Sell | EXEL | Patrick J. Haley | EVP, Commercial | 47,020 | $21.45 | $14.1B | -2.87% | +65.66% | $1.0M | -10.89% | — | Buy Now |
| Feb 15, 2024 | Sell | EXEL | Dana Aftab | CSO/EVP Disc & Trans Research | 10,630 | $20.39 | $14.1B | -2.87% | +65.66% | $216.7K | -2.17% | — | Buy Now |
| Jan 11, 2024 | Sell | EXEL | Dana Aftab | CSO/EVP Disc & Trans Research | 11,606 | $22.86 | $14.1B | -2.87% | +65.66% | $265.3K | -2.32% | — | Buy Now |
| Jan 11, 2024 | Sell | EXEL | Jeffrey Hessekiel | EVP, General Counsel & Sec | 13,061 | $22.86 | $14.1B | -2.87% | +65.66% | $298.6K | -2.16% | — | Buy Now |
| Jan 11, 2024 | Sell | EXEL | Patrick J. Haley | EVP, Commercial | 13,613 | $22.86 | $14.1B | -2.87% | +65.66% | $311.2K | -3.56% | — | Buy Now |
| Jan 11, 2024 | Sell | EXEL | Christopher J. Senner | EVP and CFO | 21,862 | $22.86 | $14.1B | -2.87% | +65.66% | $499.8K | -3.16% | — | Buy Now |
| Jan 11, 2024 | Sell | EXEL | Michael Morrissey | President and CEO | 63,717 | $22.86 | $14.1B | -2.87% | +65.66% | $1.5M | -7.41% | — | Buy Now |
| Dec 13, 2023 | Sell | EXEL | Jeffrey Hessekiel | EVP, General Counsel & Sec | 25,000 | $23.01 | $14.1B | -2.87% | +65.66% | $575.3K | -4.48% | 10b5-1 | Buy Now |
| Dec 12, 2023 | Sell | EXEL | Patrick J. Haley | EVP, Commercial | 114,149 | $20.15 | $14.1B | -2.87% | +65.66% | $2.3M | -1.43% | 10b5-1 | Buy Now |
| Nov 30, 2023 | Sell | EXEL | Jeffrey Hessekiel | EVP, General Counsel & Sec | 50,000 | $22.04 | $14.1B | -2.87% | +65.66% | $1.1M | -4.20% | 10b5-1 | Buy Now |
| Nov 16, 2023 | Sell | EXEL | Michael Morrissey | President and CEO | 19,020 | $20.98 | $14.1B | -2.87% | +65.66% | $399.0K | -1.31% | — | Buy Now |
| Nov 7, 2023 | Sell | EXEL | Michael Morrissey | President and CEO | 233,786 | $21.11 | $14.1B | -2.87% | +65.66% | $4.9M | +0.00% | — | Buy Now |
| Sep 6, 2023 | Sell | EXEL | Dana Aftab | CSO/EVP Disc & Trans Research | 12,560 | $22.27 | $14.1B | -2.87% | +65.66% | $279.7K | -2.79% | — | Buy Now |
| Sep 6, 2023 | Sell | EXEL | Jeffrey Hessekiel | EVP, General Counsel & Sec | 14,354 | $22.27 | $14.1B | -2.87% | +65.66% | $319.7K | -2.31% | — | Buy Now |
| Sep 6, 2023 | Sell | EXEL | Patrick J. Haley | EVP, Commercial | 14,354 | $22.27 | $14.1B | -2.87% | +65.66% | $319.7K | -4.27% | — | Buy Now |
| Sep 6, 2023 | Sell | EXEL | Christopher J. Senner | EVP and CFO | 17,147 | $22.27 | $14.1B | -2.87% | +65.66% | $381.9K | -2.73% | — | Buy Now |
| Sep 6, 2023 | Sell | EXEL | Michael Morrissey | President and CEO | 46,608 | $22.27 | $14.1B | -2.87% | +65.66% | $1.0M | -6.03% | — | Buy Now |
| Aug 31, 2023 | Sell | EXEL | Michael Morrissey | President and CEO | 169,942 | $22.39 | $14.1B | -2.87% | +65.66% | $3.8M | -1.70% | — | Buy Now |
| Aug 30, 2023 | Sell | EXEL | Dana Aftab | CSO/EVP Disc & Trans Research | 4,600 | $22.47 | $14.1B | -2.87% | +65.66% | $103.4K | -1.14% | 10b5-1 | Buy Now |
| Aug 28, 2023 | Buy | EXEL | Michael Morrissey | President and CEO | 663,779 | $18.45 | $14.1B | -2.87% | +65.66% | $12.2M | +3.67% | — | Buy Now |
| Aug 15, 2023 | Sell | EXEL | Dana Aftab | CSO/EVP Disc & Trans Research | 6,280 | $21.51 | $14.1B | -2.87% | +65.66% | $135.1K | -1.53% | — | Buy Now |
| Aug 15, 2023 | Sell | EXEL | Patrick J. Haley | EVP, Commercial | 7,177 | $21.51 | $14.1B | -2.87% | +65.66% | $154.4K | -2.51% | — | Buy Now |
| Aug 15, 2023 | Sell | EXEL | Jeffrey Hessekiel | EVP, General Counsel & Sec | 7,177 | $21.51 | $14.1B | -2.87% | +65.66% | $154.4K | -1.25% | — | Buy Now |
| Aug 15, 2023 | Sell | EXEL | Christopher J. Senner | EVP and CFO | 8,074 | $21.51 | $14.1B | -2.87% | +65.66% | $173.7K | -1.41% | — | Buy Now |
| Aug 15, 2023 | Sell | EXEL | Michael Morrissey | President and CEO | 23,304 | $21.51 | $14.1B | -2.87% | +65.66% | $501.3K | -3.83% | — | Buy Now |
| Aug 3, 2023 | Sell | EXEL | Patrick J. Haley | EVP, Commercial | 30,553 | $20.67 | $14.1B | -2.87% | +65.66% | $631.5K | -9.67% | — | Buy Now |
| Aug 3, 2023 | Sell | EXEL | Christopher J. Senner | EVP and CFO | 240,000 | $17.67 | $14.1B | -2.87% | +65.66% | $4.2M | +0.00% | — | Buy Now |